OPKO HEALTH INC (OPK) Fundamental Analysis & Valuation

NASDAQ:OPK • US68375N1037

Current stock price

1.14 USD
+0.04 (+3.64%)
At close:
1.1117 USD
-0.03 (-2.48%)
After Hours:

This OPK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. OPK Profitability Analysis

1.1 Basic Checks

  • OPK had negative earnings in the past year.
  • In the past year OPK has reported a negative cash flow from operations.
  • OPK had negative earnings in each of the past 5 years.
  • OPK had negative operating cash flow in 4 of the past 5 years.
OPK Yearly Net Income VS EBIT VS OCF VS FCFOPK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -100M -200M -300M

1.2 Ratios

  • OPK has a worse Return On Assets (-11.68%) than 75.00% of its industry peers.
  • OPK has a Return On Equity of -17.80%. This is in the lower half of the industry: OPK underperforms 64.00% of its industry peers.
Industry RankSector Rank
ROA -11.68%
ROE -17.8%
ROIC N/A
ROA(3y)-7.83%
ROA(5y)-7.98%
ROE(3y)-11.76%
ROE(5y)-11.62%
ROIC(3y)N/A
ROIC(5y)N/A
OPK Yearly ROA, ROE, ROICOPK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -5 -10 -15 -20

1.3 Margins

  • OPK has a better Gross Margin (33.93%) than 67.00% of its industry peers.
  • In the last couple of years the Gross Margin of OPK has declined.
  • OPK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.74%
GM growth 5Y-2.08%
OPK Yearly Profit, Operating, Gross MarginsOPK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. OPK Health Analysis

2.1 Basic Checks

  • OPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, OPK has more shares outstanding
  • The number of shares outstanding for OPK has been increased compared to 5 years ago.
  • The debt/assets ratio for OPK has been reduced compared to a year ago.
OPK Yearly Shares OutstandingOPK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
OPK Yearly Total Debt VS Total AssetsOPK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • Based on the Altman-Z score of -0.67, we must say that OPK is in the distress zone and has some risk of bankruptcy.
  • OPK has a Altman-Z score of -0.67. This is amonst the worse of the industry: OPK underperforms 82.00% of its industry peers.
  • A Debt/Equity ratio of 0.27 indicates that OPK is not too dependend on debt financing.
  • OPK has a Debt to Equity ratio of 0.27. This is in the better half of the industry: OPK outperforms 69.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Altman-Z -0.67
ROIC/WACCN/A
WACC9.25%
OPK Yearly LT Debt VS Equity VS FCFOPK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

  • OPK has a Current Ratio of 3.97. This indicates that OPK is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 3.97, OPK belongs to the best of the industry, outperforming 89.00% of the companies in the same industry.
  • A Quick Ratio of 3.52 indicates that OPK has no problem at all paying its short term obligations.
  • OPK has a better Quick ratio (3.52) than 87.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.97
Quick Ratio 3.52
OPK Yearly Current Assets VS Current LiabilitesOPK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. OPK Growth Analysis

3.1 Past

  • The earnings per share for OPK have decreased strongly by -42.86% in the last year.
  • Looking at the last year, OPK shows a very negative growth in Revenue. The Revenue has decreased by -14.90% in the last year.
  • OPK shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -15.82% yearly.
EPS 1Y (TTM)-42.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
Revenue 1Y (TTM)-14.9%
Revenue growth 3Y-15.45%
Revenue growth 5Y-15.82%
Sales Q2Q%-19.12%

3.2 Future

  • Based on estimates for the next years, OPK will show a very strong growth in Earnings Per Share. The EPS will grow by 20.45% on average per year.
  • The Revenue is expected to grow by 2.85% on average over the next years.
EPS Next Y8.62%
EPS Next 2Y9.69%
EPS Next 3Y20.45%
EPS Next 5YN/A
Revenue Next Year-7.84%
Revenue Next 2Y-1.99%
Revenue Next 3Y0.55%
Revenue Next 5Y2.85%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
OPK Yearly Revenue VS EstimatesOPK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B
OPK Yearly EPS VS EstimatesOPK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 -0.1 -0.2 -0.3 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. OPK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for OPK. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OPK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OPK Price Earnings VS Forward Price EarningsOPK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OPK Per share dataOPK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • OPK's earnings are expected to grow with 20.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.69%
EPS Next 3Y20.45%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OPK Dividend Analysis

5.1 Amount

  • No dividends for OPK!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OPK Fundamentals: All Metrics, Ratios and Statistics

OPKO HEALTH INC

NASDAQ:OPK (3/31/2026, 8:00:02 PM)

After market: 1.1117 -0.03 (-2.48%)

1.14

+0.04 (+3.64%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-26
Earnings (Next)04-28
Inst Owners26.69%
Inst Owner Change-0.04%
Ins Owners5.4%
Ins Owner Change0.02%
Market Cap865.34M
Revenue(TTM)606.88M
Net Income(TTM)-225.68M
Analysts80
Price Target3.47 (204.39%)
Short Float %8.51%
Short Ratio11.56
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)104.13%
Min EPS beat(2)42.24%
Max EPS beat(2)166.01%
EPS beat(4)2
Avg EPS beat(4)24.47%
Min EPS beat(4)-65.99%
Max EPS beat(4)166.01%
EPS beat(8)5
Avg EPS beat(8)34.69%
EPS beat(12)7
Avg EPS beat(12)33.79%
EPS beat(16)8
Avg EPS beat(16)-93.4%
Revenue beat(2)1
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-6.58%
Max Revenue beat(2)5.21%
Revenue beat(4)1
Avg Revenue beat(4)-4.33%
Min Revenue beat(4)-9.64%
Max Revenue beat(4)5.21%
Revenue beat(8)2
Avg Revenue beat(8)-1.79%
Revenue beat(12)6
Avg Revenue beat(12)3.34%
Revenue beat(16)7
Avg Revenue beat(16)2.37%
PT rev (1m)-4.45%
PT rev (3m)-7.36%
EPS NQ rev (1m)-16.67%
EPS NQ rev (3m)-16.67%
EPS NY rev (1m)-4.97%
EPS NY rev (3m)-4.97%
Revenue NQ rev (1m)-3.78%
Revenue NQ rev (3m)-3.78%
Revenue NY rev (1m)-5.12%
Revenue NY rev (3m)-5.12%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.43
P/FCF N/A
P/OCF N/A
P/B 0.68
P/tB 11.95
EV/EBITDA N/A
EPS(TTM)-0.3
EYN/A
EPS(NY)-0.27
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.24
OCFYN/A
SpS0.8
BVpS1.67
TBVpS0.1
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.68%
ROE -17.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.93%
FCFM N/A
ROA(3y)-7.83%
ROA(5y)-7.98%
ROE(3y)-11.76%
ROE(5y)-11.62%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.74%
GM growth 5Y-2.08%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.27
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.4%
Cap/Sales 2.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.97
Quick Ratio 3.52
Altman-Z -0.67
F-Score5
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)18.11%
Cap/Depr(5y)23.58%
Cap/Sales(3y)2.47%
Cap/Sales(5y)2.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-42.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-500%
EPS Next Y8.62%
EPS Next 2Y9.69%
EPS Next 3Y20.45%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.9%
Revenue growth 3Y-15.45%
Revenue growth 5Y-15.82%
Sales Q2Q%-19.12%
Revenue Next Year-7.84%
Revenue Next 2Y-1.99%
Revenue Next 3Y0.55%
Revenue Next 5Y2.85%
EBIT growth 1Y19.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year35.85%
EBIT Next 3Y34.09%
EBIT Next 5Y25.75%
FCF growth 1Y8.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y2.7%
OCF growth 3YN/A
OCF growth 5YN/A

OPKO HEALTH INC / OPK Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for OPKO HEALTH INC?

ChartMill assigns a fundamental rating of 3 / 10 to OPK.


What is the valuation status of OPKO HEALTH INC (OPK) stock?

ChartMill assigns a valuation rating of 1 / 10 to OPKO HEALTH INC (OPK). This can be considered as Overvalued.


How profitable is OPKO HEALTH INC (OPK) stock?

OPKO HEALTH INC (OPK) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for OPK stock?

The Earnings per Share (EPS) of OPKO HEALTH INC (OPK) is expected to grow by 8.62% in the next year.